GI Dynamics Announces New EndoBarrier® Data from Research with GlaxoSmithKline Presented during Digestive Disease Week

[Business Wire] – CHICAGO & SYDNEY–(BUSINESSWIRE)– GI Dynamics, Inc. ( ASX: GID ), a medical device company developing innovative treatments for type 2 diabetes and obesity, today announced that new data from a study … more

View todays social media effects on GSK

View the latest stocks trending across Twitter. Click to view dashboard

See who GlaxoSmithKline is hiring next, click here to view